Zibotentan composition containing mannitol and/or microcrystalline cellulose

Details for Australian Patent Application No. 2008309385 (hide)

Owner AstraZeneca AB

Inventors Blyth, John David; Day, Andrew John; Lennon, Kieran James

Agent Davies Collison Cave

Pub. Number AU-B-2008309385

PCT Pub. Number WO2009/047565

Priority 61/089,118 15.08.08 US; 60/979,736 12.10.07 US

Filing date 9 October 2008

Wipo publication date 16 April 2009

Acceptance publication date 20 October 2011

International Classifications

A61L 9/20 (2006.01) Disinfection, sterilisation or deodorisation of air

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/047565 Priority application(s): WO2009/047565

20 October 2011 Application Accepted

  Published as AU-B-2008309385

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008309386-Modified growth hormone polypeptides

2008309383-Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors